Moderna said on Monday its experimental influenza vaccine was found to be 26.6% more effective than a currently approved ...

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

Moderna's flu vaccine candidate, mRNA-1010, shows 26.6% efficacy in a Phase 3 trial for adults 50+. Read more here.

To estimate the relative effectiveness of the recombinant vaccine as compared with standard-dose vaccines against laboratory-confirmed influenza and influenza-related outcomes, we compared the two ...

The vaccine effectiveness in children against influenza A H1N1 viruses — the type that has predominated this flu season — ranged from 54% to 61% against flu infection requiring medical care ...

Less than half of Americans plan to get COVID or flu vaccines this year, survey finds 01:30. The effectiveness of this year's influenza vaccine was lower in South America than last season, the ...

Influenza viruses cause billions of flu infections and thousands of deaths across the globe each year. Developing an effective, long-term flu vaccine is challenging because of viral mutations.

Oct. 4, 2024 – The CDC says the influenza vaccine being used this flu season might be less effective than the one used last flu season, based on reports of how well the vaccine is working in ...

New flu data from the southern hemisphere suggests this year’s vaccine isn't as effective against severe illness as previous iterations, a finding that may not bode well for Americans as the ...

A preprint study from Cleveland Clinic suggests that the flu vaccine might not have the protective effects people expect, but doctors note that there are limitations to the research.

The 2024-2025 COVID-19 and influenza vaccines provided protection against ED/UC, outpatient visits, and hospitalizations. In the 2024-2025 season, the COVID-19 vaccine provided additional ...

Seasonal flu-related hospitalizations and outpatient visits reached a 15-year high during the 2024-25 season, according to ...